LARS anticorps (N-Term)
Aperçu rapide pour LARS anticorps (N-Term) (ABIN2442524)
Antigène
Voir toutes LARS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Affinity purification
-
Immunogène
- N-terminal region of human LARS
-
-
anti-Leucyl-tRNA Synthetase (LARS) (AA 1-270) antibody
LARS Reactivité: Humain WB, IF Hôte: Lapin Polyclonal unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 614-892) antibodyLARS Reactivité: Humain WB, IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 1118-1145), (C-Term) antibodyLARS Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB14824 unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 176-205), (N-Term) antibodyLARS Reactivité: Souris WB, FACS Hôte: Lapin Polyclonal RB14919 unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 260-509) antibodyLARS Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 183-213), (N-Term) antibodyLARS Reactivité: Humain, Souris WB, FACS, EIA Hôte: Lapin Polyclonal unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (C-Term) antibodyLARS Reactivité: Humain WB, IHC (p), EIA Hôte: Lapin Polyclonal unconjugated
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.01 % Sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Autre désignation
- LARS
-
Poids moléculaire
- 134 kDa
-
UniProt
- Q9P2J5
-
Pathways
- EGFR Signaling Pathway
Antigène
-
